• 1. An automated in-chip-catalytic–spectrophotometric method for determination of copper(ii) using a multisyringe flow injection analysis-multipumping flow system?
  Camelia Henríquez,Edwin Palacio,Víctor Cerdà Anal. Methods, 2014,6, 8494-8504
• 2. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 3. Aggregation-induced emission based on a fluorinated macrocycle: visualizing spontaneous and ultrafast solid-state molecular motions at room temperature via F?F interactions?
  Mei Zhang,Jingjing Guo,Tingting Liu,Zhanyu He,Majeed Irfan,Zujin Zhao,Zhuo Zeng J. Mater. Chem. C, 2020,8, 14919-14924
• 4. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

4-Bromo-5-methoxybenzene-1,2-diamine dihydrochloride (CAS No. 216752-62-4): A Comprehensive Overview

4-Bromo-5-methoxybenzene-1,2-diamine dihydrochloride (CAS No. 216752-62-4) is a specialized organic compound that has gained significant attention in pharmaceutical and chemical research. This brominated aromatic diamine derivative serves as a crucial intermediate in the synthesis of various bioactive molecules, particularly in the development of novel therapeutic agents.

The molecular structure of 4-Bromo-5-methoxybenzene-1,2-diamine dihydrochloride features a benzene ring substituted with bromine at the 4-position, a methoxy group at the 5-position, and two amino groups at the 1,2-positions. The dihydrochloride salt form enhances its stability and solubility, making it particularly valuable for laboratory applications. Recent studies highlight its potential as a building block for heterocyclic compound synthesis, which aligns with current research trends in medicinal chemistry.

In pharmaceutical applications, this compound has shown promise as a precursor for the development of kinase inhibitors and antimicrobial agents, addressing the growing need for new treatments against drug-resistant pathogens. The presence of both bromine and methoxy substituents offers unique reactivity patterns that researchers are exploring for targeted drug design. This aligns perfectly with current industry focus on precision medicine and structure-activity relationship studies.

The synthesis and applications of 4-Bromo-5-methoxybenzene-1,2-diamine HCl salt have become particularly relevant in the context of recent advancements in automated organic synthesis and high-throughput screening technologies. Many researchers are searching for information about "brominated aromatic amine applications in drug discovery" or "methoxy-substituted benzene derivatives as pharmaceutical intermediates," making this compound a subject of significant scientific interest.

From a chemical perspective, the dihydrochloride form of 4-Bromo-5-methoxybenzenediamine offers several advantages in synthetic chemistry. The salt form typically exhibits improved crystallinity and handling properties compared to the free base, which is particularly important for process chemistry and scale-up operations. These characteristics make it valuable for current research in continuous flow chemistry and green chemistry initiatives.

Recent publications have highlighted the use of CAS 216752-62-4 in the development of fluorescent probes and molecular sensors. This application leverages the compound's aromatic structure and functional group diversity, responding to the growing demand for bioimaging agents and diagnostic tools in biomedical research. The compound's potential in material science applications, particularly in the development of organic electronic materials, is also being explored.

Quality control and analytical characterization of 4-Bromo-5-methoxy-1,2-benzenediamine dihydrochloride typically involve techniques such as HPLC, mass spectrometry, and NMR spectroscopy. These analytical methods ensure the compound meets the stringent purity requirements for pharmaceutical applications, addressing common search queries about "characterization of aromatic diamine derivatives" and "quality control of pharmaceutical intermediates."

The stability and storage conditions of 4-Bromo-5-methoxybenzene-1,2-diamine dihydrochloride salt are frequently discussed topics among researchers. Proper handling typically requires protection from light and moisture, with recommended storage at controlled room temperature. These considerations are particularly important for laboratories focusing on compound libraries and drug discovery programs.

In the context of intellectual property, several patents have emerged that utilize 216752-62-4 as a key intermediate, particularly in claims related to small molecule therapeutics and catalytic systems. This patent activity reflects the compound's growing importance in both academic and industrial research settings.

As research continues to evolve, 4-Bromo-5-methoxybenzene-1,2-diamine dihydrochloride maintains its position as a valuable tool for synthetic chemists. Its unique combination of substituents offers multiple points for further functionalization, making it particularly useful for combinatorial chemistry approaches and structure-optimization studies in drug development pipelines.

The commercial availability of CAS 216752-62-4 from specialty chemical suppliers has increased in recent years, responding to growing demand from both academic and industrial researchers. This availability supports current trends in outsourced drug discovery and collaborative research initiatives across the pharmaceutical and biotechnology sectors.

Looking forward, the applications of 4-Bromo-5-methoxybenzene-1,2-diamine dihydrochloride are expected to expand further, particularly in emerging areas such as proteolysis targeting chimeras (PROTACs) and covalent inhibitor development. These applications take advantage of the compound's ability to serve as a versatile scaffold for the design of biologically active molecules with improved pharmacological properties.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)